Acenocoumarol as a risk factor for calciphylaxis: a feature clinicians should be aware of

被引：0

作者：

Wenstedt, E. F. E. ^{[1
]}

Huysentruyt, C. J. ^{[2
]}

Konings, C. J. A. M. ^{[1
]}

机构：

[1] Catharina Hosp, Dept Internal Med, Eindhoven, Netherlands

[2] Catharina Hosp, Dept Pathol, Eindhoven, Netherlands

来源：

NETHERLANDS JOURNAL OF MEDICINE | 2017年 / 75卷 / 04期

关键词：

Calciphylaxis; acenocoumarol; warfarin; calcaemic uraemic arteriolopathy; vitamin K antagonist; non-uraemic; HYPERBARIC-OXYGEN; WARFARIN; PATIENT; THERAPY;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In contrast with uraemic calciphylaxis in end-stage renal disease, causes of and risk factors for non-uraemic calciphylaxis are relatively unknown to clinicians and have yet to become fully established. This report describes a case of non-uraemic calciphylaxis, in which the use of acenocoumarol might have been a risk factor. It is important to raise awareness about this association among clinicians, as vitamin K antagonists have to be stopped for an optimal treatment of this severe condition.

引用

页码：161 / 164

页数：4

共 50 条

[21] CHOLESTEROL SCREENING IN CHILDREN - SHOULD OBESITY BE A RISK FACTOR
GLASSMAN, MS
SCHWARZ, SM
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 1993, 12 (03) : 270 - 273
[22] Should we use ethnicity as a risk factor for infection?
Leibovici, L.
CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (05) : 533 - 533
[23] SHOULD FIBROMYALGIA BE INCLUDED AS A RISK FACTOR FOR BONE LOSS?
Bumbea, A. M.
Traistaru, R.
Dumitrascu, R.
Bumbea, B.
Borcan, M.
Musetcscu, A.
Rogoveanu, O.
OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S342 - S343
[24] Should we consider hyperhomocystinemia as a factor of vascular risk?
Quéré, I
REVUE DE MEDECINE INTERNE, 2000, 21 (03): : 229 - 230
[25] Who's keeping score? Risk assessment models should be built for the clinicians using them
Mlaver, Eli
Shaffer, Virginia O.
AMERICAN JOURNAL OF SURGERY, 2024, 235
[26] Anti-GAD positive stiff-person syndrome and cerebellar ataxia: two treatable conditions that clinicians should be aware of
Ferraz, Henrique Ballalai
ARQUIVOS DE NEURO-PSIQUIATRIA, 2012, 70 (09) : 655 - 656
[27] Symptomatic DCIS is a risk factor for invasion and should be managed accordingly
Dimopoulos, N.
Williams, K.
Kirwan, C. C.
Johnson, R.
Howe, M.
Bundred, N. J.
CANCER RESEARCH, 2012, 72
[28] Should we consider gestational diabetes a vascular risk factor?
Bo, S.
Valpreda, S.
Menato, G.
Bardelli, C.
Botto, C.
Gambino, R.
Rabbia, C.
Durazzo, M.
Cassader, M.
Massobrio, M.
Pagano, G.
ATHEROSCLEROSIS, 2007, 194 (02) : E72 - E79
[29] Risk of recoarctation should not be a deciding factor in the timing of coarctation repair
Pearl, JM
Manning, PB
Franklin, C
Beekman, R
Cripe, L
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (06): : 803 - 805
[30] Should we continue to use BMI as a cardiovascular risk factor?
Franzosi, Maria Grazia
LANCET, 2006, 368 (9536): : 624 - 625

← 1 2 3 4 5 →